Study on Adjuvant Chemotherapy After Total Two-field Lymph Node Dissection of Thoracic Esophageal Squamous Cell Carcinoma
Status:
Recruiting
Trial end date:
2029-05-01
Target enrollment:
Participant gender:
Summary
Patients with thoracic esophageal squamous cell carcinoma after total two-field lymph node
dissection were randomized into the adjuvant chemotherapy group or the postoperative
observation group